139 related articles for article (PubMed ID: 11753970)
1. Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumors.
Toretsky JA; Steinberg SM; Thakar M; Counts D; Pironis B; Parente C; Eskenazi A; Helman L; Wexler LH
Cancer; 2001 Dec; 92(11):2941-7. PubMed ID: 11753970
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.
Borinstein SC; Barkauskas DA; Krailo M; Scher D; Scher L; Schlottmann S; Kallakury B; Dickman PS; Pawel BR; West DC; Womer RB; Toretsky JA
Cancer; 2011 Nov; 117(21):4966-76. PubMed ID: 21480204
[TBL] [Abstract][Full Text] [Related]
3. Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study.
Borinstein SC; Barkauskas DA; Bernstein M; Goorin A; Gorlick R; Krailo M; Schwartz CL; Wexler LH; Toretsky JA
Pediatr Blood Cancer; 2014 Apr; 61(4):749-52. PubMed ID: 24178953
[TBL] [Abstract][Full Text] [Related]
4. Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma.
Rodriguez-Galindo C; Poquette CA; Daw NC; Tan M; Meyer WH; Cleveland JL
Med Pediatr Oncol; 2001 Jun; 36(6):605-11. PubMed ID: 11344491
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.
Aksoy Y; Aksoy H; Bakan E; Atmaca AF; Akçay F
Urol Int; 2004; 72(1):62-5. PubMed ID: 14730168
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
Miyata Y; Sakai H; Hayashi T; Kanetake H
Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585
[TBL] [Abstract][Full Text] [Related]
7. Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.
Shariat SF; Lamb DJ; Kattan MW; Nguyen C; Kim J; Beck J; Wheeler TM; Slawin KM
J Clin Oncol; 2002 Feb; 20(3):833-41. PubMed ID: 11821468
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.
Holdaway IM; Mason BH; Lethaby AE; Singh V; Harvey VJ; Thompson PI; Evans BD
ANZ J Surg; 2003 Nov; 73(11):905-8. PubMed ID: 14616567
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer.
Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D
Tumour Biol; 2014 Sep; 35(9):9303-9. PubMed ID: 24943688
[TBL] [Abstract][Full Text] [Related]
10. Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.
Toriola AT; Ziegler M; Li Y; Pollak M; Stolzenberg-Solomon R
Ann Surg Oncol; 2017 Oct; 24(11):3212-3219. PubMed ID: 28681154
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
[TBL] [Abstract][Full Text] [Related]
12. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
[TBL] [Abstract][Full Text] [Related]
13. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
[TBL] [Abstract][Full Text] [Related]
15. Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.
Karna E; Surazynski A; Orłowski K; Łaszkiewicz J; Puchalski Z; Nawrat P; Pałka J
Int J Exp Pathol; 2002 Oct; 83(5):239-45. PubMed ID: 12641820
[TBL] [Abstract][Full Text] [Related]
16. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
[TBL] [Abstract][Full Text] [Related]
18. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs.
Song DW; Ro WB; Sur JH; Seung BJ; Kang HM; Kim JW; Park SH; Park HM
J Vet Sci; 2021 Nov; 22(6):e77. PubMed ID: 34697923
[TBL] [Abstract][Full Text] [Related]
20. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
